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The aim of this study was to investigate the beliefs that patients with advanced cancer held about the curability of their cancer, their
use of alternatives to conventional medical treatment, and their need to have control over decisions about treatment. Of 149
patients who fulfilled the criteria for participation and completed a self-administered questionnaire, 45 patients (31%) believed their
cancer was incurable, 61 (42%) were uncertain and 39 (27%) believed their cancer was curable. The index of need for control over
treatment decisions was low in 53 patients (35.6%) and high in only 17 patients (11.4%). Committed users of alternatives to
conventional medical treatments were more likely to believe that their cancer was curable (Po0.001) and to have a higher need for
control over decisions about treatment (Po0.004). The mean need for control scores were highest in patients who believed that
their cancer was curable, or who were uncertain about the curability of their cancer, but who acknowledged that their oncologist had
reported that the cancer was incurable. The diverse beliefs, attitudes and actions of these patients were consistent with a range of
psychological adaptions to a life-threatening illness, some realistic and others illusory. Illusory responses influence what
communication can achieve in daily oncology practice.
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Accurate communication of information underpins the contem-
porary Western medical values of truth telling and patient
participation in decision making, as well as the core ethical,
cultural and legal values of informed consent. Recent research has
placed a considerable emphasis on effective communication of bad
news (Fallowfield, 1993; Sell et al, 1993; Ptacek and Eberhardt,
1996) and numerous approaches have been recommended to
evaluate and improve communication (Fallowfield, 1993;
McConnell et al, 1999; Schofield et al, 2001). Yet relatively little
attention has been paid as to what patients believe about what they
are told and how they respond to bad news.
In advanced cancer, there is growing evidence that some
patients have unrealistic expectations of treatments of minimal
(Slevin et al, 1990) or unproven efficacy (Bagenal et al, 1990;
Daugherty et al, 1995; Miller et al, 1998), including a belief that
their cancer is curable (Slevin et al, 1990; Yates et al, 1993; Butow
et al, 1999; Richardson et al, 2000). In a secondary analysis of data
that evaluated the beliefs and attitudes of patients about their
diagnosis, prognosis, satisfaction with and use of treatments in
advanced cancer, we showed that positive illusory responses,
characterised by a belief in curability, a strong will to live and a
committed use of alternatives to conventional medical treatments
were associated with better quality of life (Beadle et al, 2004). The
purpose of the current analysis is to evaluate the relationship
between the beliefs held by these patients about the curability of
their cancer and their need to have control over decisions about
treatment.
MATERIALS AND METHODS
Participants
The details of this prospective cross-sectional study have been
published elsewhere (Yates et al, 1993; Beadle et al, 2004) and its
intent was to capture the immediate views of patients about their
attitudes and beliefs following a diagnosis of advanced cancer. In
summary, eligible patients had locally advanced or metastatic
cancer, measurable or evaluable disease, ambulatory status
(performance status ECOG 0–3), an estimated survival between
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l3 months and 2 years, and a time interval since last outpatient
review of less than 3 months. All were potential candidates for
active treatment of their cancer as an outpatient, and 90% were
having systemic and/or radiation treatments at the time of this
study. The clinical standard of practice was to inform all patients
about the extent of their cancer, its incurability, the expectations of
a limited lifespan, the palliative goal of systemic and radiation
treatment, the response to treatment and their overall progress.
The study was approved by the Ethics Committees of the relevant
institutions and all participants provided written informed consent
after explanation of the purpose of the study.
Questionnaire
Of five items that examined attitudes and beliefs about treatment
decisions, two statements specifically asked patients about their
need to have control over decisions about treatment. On a scale of
1 (very true) to 4 (not true at all), patients were asked to report
their need for control over decisions about treatment. One item
was reverse coded and the scores of both questions were added to
create an index, with a potential range of 2 (low need for control)
to 8 (high need for control).
Patients were also asked to indicate the degree to which they
utilized and believed in the efficacy of alternatives to conventional
medical treatments. Details of therapies and the practitioners who
prescribed alternatives to conventional medical treatments are
described elsewhere (Yates et al, 1993) in a larger sample of
patients. Therapies included vitamins and tonics, methods of
meditation and relaxation, special diets, faith healing, herbal
remedies, and methods of detoxification and immune stimulation.
A quantitative analysis of questions looking at the use of, and
commitment to, these alternatives was followed by a detailed
qualitative assessment of patients’ beliefs and attitudes. Committed
users were characterised by a strong adherence to the use of
alternatives and a strong belief that alternatives were a core part of
their treatment. A total of 33 patients fulfilled the criteria while the
remaining 116 patients did not utilise alternatives or made only
minimal alternative changes to their lifestyle.
The concept of belief in curability of cancer was assessed by
three items. Two items asked patients about their belief in the
curability of their cancer and how long they expected to survive,
and one question asked their recollection of the report by their
oncologist about the curability of their cancer (Table 1). The
respondents’ beliefs about curability and their recollection of what
their oncologist had reported were each categorised into three
groups: curable, uncertain and incurable.
Statistical analysis
Data were analysed using the statistical package SPSS. Kendall
Taub correlation coefficients were calculated among items that
addressed a particular concept. Associations between categorised
variables were examined with w
2-tests. Variation among subgroups
in mean need for control scores was examined using analysis of
variance (three subgroups) or t-tests (two subgroups).
RESULTS
Participants
During the 10-week period of this prospective study, 178
consecutive patients potentially fulfilled the criteria for participa-
tion. After exclusions, 149 patients fulfilled the criteria for
participation and completed the questionnaire.
Belief in curability and committed use of alternatives
In this study, 39 patients (27%) believed that their cancer was
curable, 61 (42%) were uncertain about the curability of their
cancer, and 45 (31%) believed that their cancer was incurable.
Table 2 shows the distribution of belief in curability according to
the committed use of alternatives to conventional medical
treatments. Committed users of these alternatives were more likely
to believe that their cancer was curable than the remaining patients
(Po0.001).
Need for control over treatment decisions
The statements of need for control over decisions about treatment
and the distribution of scores are shown in Table 3. The two items
Table 1 Index of belief in curability
I believe that my cancer:
1. Is curable
2. Is not curable
3. Don’t know
Regardless of what your doctors have told you, how long do you expect to
survive?
1. My condition is curable
2. One year or more
3. Some months
4. Some weeks
5. No idea/don’t know
My doctor says my cancer
1. Is curable
2. Is not curable
3. I am not certain what my doctor has told me about cure
4. My doctor has said nothing to me about cure
Table 2 Committed use of alternatives to conventional medical
treatment and the distribution of belief in curability
Committed use No/minimal use
(n¼33) (n¼116)
Belief in curability
a Number (%) Number (%) Number (%)
Curable 39 (27) 17 (52) 22 (19)
Uncertain 61 (42) 10 (30) 54 (47)
Incurable 45 (31) 4 (18) 40 (34)
X¼13.37 (df¼2)
Po0.001
aFour items incomplete.
Table 3 Need for control over treatment decisions
Statements
I leave it up to my doctor to decide what is best for my cancer.
I need to have control over decisions made about my cancer
treatment
Scores Number Percentage
2 32 21.5
3 21 14.1
4 24 16.1
5 42 28.2
6 11 7.4
7 6 4.0
8 11 7.4
Missing 2 1.3
Total 149 100
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lcomprising this index had a Kendal Taub of 0.32 (Po0.001). A
total of 53 patients (35.6%) had a very low need for control (scores
2,3), with 119 (79.9%) scoring at or below the mid-point of 5. Only
17 patients (11.4%) had a high need for control over decisions
about treatment (scores 7,8).
Need for control and belief in curability
Table 4 shows the mean need for control scores distributed
according to the use of alternatives to conventional medical
treatments, and belief in curability. Parametric statistical tests were
used for these analyses since the normality assumptions for the
need for control scale were satisfied. The mean need for control
scores were significantly higher in patients who were committed
users of alternatives than the mean scores of those patients who
did not use alternatives or who made only minimal changes to
their lifestyle (Po0.004). There was a trend for patients who
believed that their cancer was curable to have a higher mean need
for control score than patients who were uncertain about the
curability of their cancer or who did not believe that their cancer
was curable (P¼0.11 for the three groups; P¼0.04 when the group
who believed in curability was compared with the remaining
groups).
Table 5 shows the mean need for control scores distributed
according to patients’ beliefs in curability and their recollection of
the reports by their oncologists. Of the 45 patients (31%) who
believed that their cancer was incurable, 37 recollected a report of
incurability by their oncologist and eight were uncertain of their
oncologist’s report. For this group, a recollection of incurability
generally corresponded with the intended communication by the
treating oncologist. Of the remaining 100 patients, 39 (27%)
believed their cancer was curable and 61 (42%) were uncertain
about curability. Of these patients, 28 recollected a report of
curability of their cancer by their oncologist and 33 were uncertain
about the report by their oncologist. However, 39 patients who
believed their cancer was curable or who were uncertain about its
curability acknowledged a report of incurability by their oncolo-
gist. The mean need for control scores were highest in those
patients who recollected a report of incurability by their oncologist
but believed their cancer was curable (5.47) or were uncertain
about the curability of their cancer (5.25). The mean scores of
patients who believed their cancer was curable differed signifi-
cantly from the mean scores of patients who believed their cancer
was incurable and who recollected a reported incurability by their
treating oncologist (P¼0.015).
DISCUSSION
Studies of disclosure of bad news recognise the need to
communicate complex information effectively in an emotionally
charged consultation. At odds are the practitioner’s duty to truth
telling and the patient’s cognitive and emotional appraisal of bad
news. Techniques for delivery of bad news are well documented in
oncology (Sell et al, 1993; Girgis and Sanson-Fisher, 1995), but
studies also recognise that information can be misunderstood or
forgotten (Ptacek and Eberhardt, 1996; McConnell et al, 1999;
Schofield et al, 2001). The use of audiotapes in medical
consultations is a logical antidote to misunderstanding (Hogbin
and Fallowfield, 1989; Damian and Tattersall, 1991; Deutsch, 1992;
Dunn et al, 1993; McHugh et al, 1995) but, for patients with a poor
prognosis, bad news can increase psychological distress (McHugh
et al, 1995) and the potential for maladaptive responses. To date,
most studies have focused on initial contact with bad news but not
the subsequent coping patterns by patients. In one qualitative
study, however, patients with small-cell lung cancer adapted to bad
news by exhibiting false optimism during the course of their illness
(The et al, 2000). In the current study, only 45 patients (31%)
believed their cancer was incurable and this belief correlated with a
recollection of a report of incurability by their oncologists in 37
cases. By contrast, 39 patients (27%) believed their cancer was
curable, a result similar to that reported in other patients with
metastatic cancer (Mackillop et al, 1988), while 61 patients (42%)
were uncertain about the curability of their cancer. While
inadequate communication and false optimism are plausible
explanations of the discrepancies between patients’ beliefs and
their recollections of the reports by their oncologists, 39 (36%) of
the 108 patients who believed their cancer was curable or were
uncertain about its curability acknowledged a report of incur-
ability by their oncologist. For these 39 patients, communication
was adequate but at odds with their own beliefs.
In addition to assessing patients’ beliefs about curability, this
study evaluated the actions patients took to influence their
outcome. An index of need for control over decisions about
treatment was skewed with 36% scoring at the lower end of the
range and only 11.4% at the upper end. Patients who were
committed users of alternatives to conventional medical treat-
ments, however, had a higher need for control scores (Table 4) and
were more likely to believe that their cancer was curable (Table 2)
than the remaining patients. Furthermore, the scores were highest
in those patients who acknowledged a report of incurability by
their oncologist but who believed their cancer was curable or were
uncertain about curability (Table 5).
In recent years, increasing importance has been placed on the
development of methods to improve comprehension about the
likely value of treatments (Pater et al, 1994; Llewellyn-Thomas,
Table 4 Mean need for control scores, patients’ beliefs in curability, and
use of alternatives to conventional medical treatment
Number
Need for control mean
score
Committed use of alternative treatment
a
Committed 33 6.09
No/minimal 114 3.76
t(1,145)¼64.55, Po0.004
Belief in curability
b
Curable 38 4.79
Uncertain 63 4.16
Incurable 45 4.02
F¼(2,143)¼2.24, P¼0.11
Curable 38 4.79
Uncertain &
Incurable
108 4.10
t(1,144)¼4.35, P¼0.04
aTwo items missing.
bThree items missing.
Table 5 Belief in curability
a and need for control scores
b
Recollections of oncologists’ reports
of curability
Curable Uncertain Incurable
Patients beliefs
in curability X ¯ (N) X ¯ (N) X ¯ (N) P
Curable 3.87 (16) 5.25 (8) 5.47 (15) 0.06 f(2,35)¼3.14
Uncertain 4.00 (12) 4.32 (25) 4.00 (24) NS
Incurable — (0) 4.87 (8) 3.84 (37) NS
P NS NS 0.015
aFour items incomplete group.
bX ¯ is the mean score for each group; (N) is the
number of patients in each.
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l1995; O’Connor, 1995; Richardson and Detsky, 1995). However,
studies also show that patients are prepared to accept a lower level
of benefit from treatment than healthy surrogates (Sackett and
Torrance, 1978; Boyd et al, 1990; Llewellyn-Thomas et al, 1991;
Coates and Simes, 1992; Llewellyn-Thomas et al, 1992). These
results suggest that illness-related behaviour is more than the sum
of communicated information. In the current study, an assessment
of belief in curability showed discrepancies between the intent of
the oncologists to present accurate information about prognosis,
and the beliefs of some patients. While inaccurate or falsely
optimistic communication are possible explanations of some
discrepancies, the range of beliefs and attitudes suggests that at
least some patients reorientated the experience of adverse
information to a positive imaginative outcome. In particular,
some patients who exhibited a high need for control were not
passive recipients of information but actively shaped information
and undertook strategies to support positive illusory beliefs.
Illusions contribute to the diversity of human responses to
both information and circumstance, and positive illusions are
well recognised in both health and illness, sometimes with
beneficial outcomes (Taylor and Brown, 1988). The extent to
which some patients reshape information to meet their own
conative, cognitive and affective dispositions influences the
intended goals of both communication and informed consent in
oncology practice, and also plausibly explains their vulnerability to
biased information.
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